Novartis (Sweden)-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2023

  1. Phase II Trial of Dabrafenib Plus Trametinib in Relapsed/Refractory BRAF V600 Mutant Pediatric High-Grade Glioma

    Journal of Clinical Oncology, Vol. 41, Núm. 33, pp. 5174-5183